180 per cent dividend alert: Don’t miss out on the action in this high ROCE small-cap stock!
The stock is currently trading at a P/E of 35.1 and has a ROE of 30.8 per cent and ROCE of 41.1 per cent.
On Monday, shares of Thyrocare Technologies zoomed more than 4.3 per cent to make an intraday high of Rs 465.80. The scrip witnessed positive traction.
The company announced to the exchange on April 7, 2023, that during their board meeting held on the same day, the Board of Directors declared an interim dividend of Rs 18 per share (equivalent to 180 per cent of the face value of Rs 10) for the 2022-23 financial year. The board also established April 20, 2023, as the record date for determining shareholders' entitlement to the interim dividend.
In Q3FY23, the net sales of the company surged 9.05 per cent from December 2021 quarter to Rs 128.03 crore. The EBITDA level dipped by 21.57 per cent from corresponding quarter last year to Rs 29.96 crore. The net profit slipped by 31.53 per cent from last year’s same quarter to Rs 14.72 crore.
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. The stock is currently trading at a P/E of 35.1 and has a ROE of 30.8 per cent and ROCE of 41.1 per cent.
Keep a close eye on this trending stock.